Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
154M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
19.9M
-
Shares change
-
-1.31M
-
Total reported value, excl. options
-
$156M
-
Value change
-
-$14.7M
-
Number of buys
-
25
-
Number of sells
-
-25
-
Price
-
$7.84
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q3 2021
66 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 as of Q3 2021.
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.9M shares
of 154M outstanding shares and own 12.95% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7.23M shares), Avidity Partners Management LP (2.42M shares), Abingworth LLP (1.62M shares), Point72 Asset Management, L.P. (1.28M shares), BlackRock Inc. (1.25M shares), VANGUARD GROUP INC (1.07M shares), JOHNSON & JOHNSON (729K shares), Ally Bridge Group (NY) LLC (425K shares), Ikarian Capital, LLC (392K shares), and DAFNA Capital Management LLC (376K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.